Module 3 - Affect Disorders Flashcards

1
Q

How do you diagnose bipolar disorder?

A

A distinct period of abnormally and persistently elevated, expansive, and irritable mood for >1week (or admission) +/- grandiose delusions + A distinct period of abnormally and persistently elevated, expansive, and irritable mood for >2 weeks +/- nihilistic delusions.
3 symptoms (or 4 if irritable):
- Inflated self-esteem or grandiosity
- Decreased need for sleep
- Talkative or pressure of speech
- Flight of ideas or racing thoughts
- Distractibility
- Psychomotor agitation or increase in
activity (socially, work, sexually)
- excessive involvement in pleasurable
activities with potential neg. conseq.
5 symptoms of:
- depressed mood most of the day
- diminished pleasure in activities
- significant weight loss (>5% /month), or change in appetite
- insomnia or hypersomnia
- psychomotor agitation or retardation
- fatigue or loss of energy
- feelings of worthlessness or guilt
- diminished ability to think, concentrate, or indecisiveness
- recurrent thoughts of death or suicide.
BP-I = mania/mixed +/- depression
BP-II = hypomania + depression
Cyclothymic = hypomania + subdepressive
Young Mania Rating Scale - 12 catergories, points out of 4 or 8 and then >20 is likely to be a manic episode and <12 is in remission.
The Hamilton Rating Scale for Depression - 21 categories out of 2 or 4, 8-13 is mild depression, 19-22 is severe depression.
Symptoms present 50% time, depressive:manic = 3:1, presence sybthreshold 1/3 time, functional impairment in 1/3 cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the epidemiology?

A

£2 billion annual cost to UK, 10% NHS use, 4% non-health-care and 86% indirect sots. Lifetime prevalence 1-2%, subthreshold forms of bipolar 5.1%.
10-30yo onset, 50% adults report childhood/adolescent onset. Increase in diagnosis in adolescents (400%) and children (500%) But often diagnosed 10 years late, because heterogeneity, no clear definition episodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors for bipolar disorder?

A

75% heritable, if 2 affected 1st degree relatives. Cross-Disorder Group of PGC 2013
exhaustion, drugs (abuse and medication), seasons, pregnancy, insomnia , family conflict, high grades (15 year olds with A grades 4-fold increased risk, those with poorest grades have double risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the kindling hypothesis?

A

Initial episodes are triggered by life stressors but successive episodes may occur autonomously. Possibly changes in receptors, ion channels, sprouting, etc. which causes reorganisations in neuronal circuitry and increased excitability. Found this with epilepsy in mice (amygdala-kindled seizures and then spontaneous). Eg. maybe cocaine increases psychomotor activity and then there’s tolerance and then reverse tolerance which causes sensitisation of brain tissue and neural activity that leads to functional and structural changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the social rhythm disruption theory?

A

Episodes are triggered by loss of regular social rhythms and circadian activity patterns.
Life events cause changes in social cues and changes in social rhythms (eg. sleeping patterns, etc.) which and change internal biological rhythms (eg. melatonin, cortisol) and then somatic symptoms (eg. headaches, insomnia) and then an episode.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the Behavioural Approach System Dysregulation?

A

BAS= psychobiological system implicated in facilitating approach to rewards in the environment
(explain reward-related risky behaviours)
Vulnerability/High BAS sensitivity leads to BAS activation or deactivation relevent event (stress) which leads to excessive BAS activation or deactivation and then a manic or depressive episode. Allay 2010

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the Response Inhibition deficits mechanism?

A

(hypo)manic risk-taking reflects a
general failure to inhibit behavioral responses regardless of the reward context
Abnormalities in prefrontal and anterior cingulate cortices: involved in cognitive control needed for response inhibition may have a role in the aetiology of BD. Dis Bora 2009

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Disruptive Mood Dysregulation Disorder?

A
  1. Severe recurrent temper outbursts manifested verbally (e.g., verbal rages) and/or behaviorally (e.g., physical aggression toward people or property) that are grossly out of proportion in intensity or duration to the situation or provocation.
  2. The temper outbursts are inconsistent with developmental level (e.g., the child is older than you would expect to be having a temper tantrum).
  3. The temper outbursts occur, on average, three or more times per week.
  4. The mood between temper outbursts is persistently irritable or angry most of the day, nearly every day, and is observable by others (e.g., parents, teachers, friends).
  5. The above criteria have been present for 1 year or more, without a relief period of longer than 3 months. The above criteria must also be present in two or more settings (e.g., at home and school), and are severe in at least one of these settings.
  6. The diagnosis should not be made for the first time before age 6 years or after age 18. Age of onset of these symptoms must be before 10 years old.
  7. There has never been a distinct period lasting more than 1 day during which the full symptom criteria, except duration, for a manic or hypomanic episode have been met.
  8. The behaviors do not occur exclusively during an episode of major depressive disorder and are not better explained by another mental disorder.
    LONG TERM FOLLOW UP SHOWS HIGH RATE OF DEPRESSION AND ANXIETY DISORDER AND NOT BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prognosis of BP?

A

Rapid cycling (4 episodes/year), more in women, 16%, less treatment response, 30-40% cases previous exposure antidepressants.
Recurrence - 37% at 1 year, 61% at 4 years.
Polarity - 50-65% start with depressive episode (initial episode presentation is more predominant symptom) and depressive episode has worse prognosis (suicidality increase, earlier onset, rapid cycling, mixed symptoms). Manic polarity is associated with cognitive deterioration.
Bipolar patients have the highest rate of suicide of all psychiatric disorders. (Highest early in illness, male, previous self harm, alcohol and drug use disorders, previous criminality, hopelessness). Non-fatal suicidal behaviour 30%.
Risk of violent (8% in males) and non-violent crime (18% in males) in firs 5 years
BP-II more likely to have hospital admissions and outpatient treatment.
Life expectancy - die 9 years earlier - 2-fold physical illness risk (COPD, pneumonia, CV, cancer) and 10-fold suicide risk women, 8-fold men.
Other comorbidities: OCD 10-fold, substance use disorder 4-fold, anxiety disorder 7-fold, ADHD 7-fold, pathological gambling 2-fold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathophysiology of bipolar disorder?

A

Primary deficit in serotoninergic transmission (mood, memory, sleep, cognition) with catecholamine (DA, NA, A) changes over the top (excessive -> mania, deficit -> depressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the treatment for bipolar disorder?

A

Non-pharmacological: Psychoeducation for patient, family, school
CBT, InterPersonal and Social Rhythm Therapy, Family-focused therapy.
Pharmacological: Atypical antipsychotics, mood stabilisers, antidepressants

Manic episode: If a person develops mania or hypomania and is not taking an antipsychotic or mood stabiliser, offer haloperidol, olanzapine, quetiapine or risperidone
aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder
Depressive episode: offer fluoxetine +/- olanzapine, or quetiapine on its own, or (second-line: lamotrigine)
Long term: Lithium, second-line: + valproate (not girls of reproductive age), if lithium poorly tolerated: consider valproate or olanzapine instead or, if it has been effective during an episode of mania or bipolar depression, quetiapine.
Lithium and divalproex possibly neuroprotective, increase neurotrophic factors and decrease apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the epidemiology of depression?

A
4-10% MDD, 2.5-5% Dysthymia
DALYS: -> 1990,  4th most common
-> 2020 2nd most common
Adults with depression, 75% had psychiatric diagnosis before 18 years, 50% before age 15 years
Worse physical health outcomes
Suicide: 1% all deaths, 2/3 depressed
Violence against others
Marital family relationships, child neglect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the symptoms of depression?

A
Symptoms pervasive, Impairing, Present for at least 2 weeks:
Low mood/sadness
Anhedonia
Loss of energy
Changes to:
Appetite / Weight-(+/-)
Sleep- (+/-)
Poor Concentration
Thoughts:Pessimism,Guilt 
Self esteem/confidence 
Libido 
Psychomotor agitation/retardation
Self harm / Suicide
Associated with anxiety disorders, eating disorders and conduct problems.
Mild, moderate, severe With/without psychotic features
ICD 10
1.Dep D/O- Single episode
2.Dep D/O- Recurrent
3.Persistent: Dysthymic D/O
DSM-5
1.Major Depressive Disorder
2.Persistent Depressive D/O
3.Disruptive Mood Dysregulatn 4.Premenstrual Dysphoric D/O

Subgroup seasonal patterns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is adolescent depressive disorder?

A

Irritability instead of sadness/low mood
Especially in boys
Somatic complaints and social withdrawal are common
Psychotic symptoms rare before
mid- adolescence
2-6%
Females 2x more likely than males at 15yo
- High rates of persistence and recurrence (20% in 1 yr) Lewinson 1994
- Adol DepDisorder -> 40-70% recurrence in adulthood
-> 2-7x increased risk as an adult Rao et al, 1998

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment for depression?

A

The amine hypothesis suggests that depression results from hypo-activity of monoamine neurotransmitter reward systems
Increased gonadal hormones ->? Direct CNS effect mood (Oestradiol)

Mild depression 
Cognitive behavioural therapy [Individual or group]
Interpersonal psychotherapy for adolescents 
Moderate – Severe Depression
Antidepressants eg SSRI’s: fluoxetine
Could be SSRI + CBT
Lasts on average 4 to 6 months 
Relapse common (50%+  >1 episode)

Experience sampling/Eco. Momentary Ass (EMA)(Armey et al 2015) ?
Neural predictors: animal studies, imaging (PET fMRI) ->
Fronto-limbic interactions, hippocampal size, neurogenesis (Heller 2015)
Exercise: ?Mild to moderate, ?Neuroinflammation/trophins
Pharmacogenetics (Zajkowska, 2014)
Therapygenetics (Eley et al 2012)
Internet-based therapies (Cuijpers et al, 2015)
Prevention, guided self help, blended, relapse prevention, maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the risk factors for depression?

A

Experimentation tobacco, alcohol, drugs
monozygotic twins reared together:- 76% concordance
adverse childhood experiences
Poverty, homelessness, unemployment , chronic physical illness, lack of confiding relationship, separation, loss

17
Q

What are the pros and cons of lithium?

A

Lithium - first line in bipolar disorder. Also in major depressive disorder if not responsive to other drugs and in schizophrenia.
Mechanism of action unknown, possibilities include:
inhibition of inositol monophosphatase and glycogen synthase kinase (GSK)3β.
Nassar - lithium has anti-inflammatory effects that may contribute to its therapeutic efficacy
Rapoport - arachidonic acid cascade
Chronic Li treatment stabilizes free-running activity rhythms, by improving day-to-day rhythmicity of the activity, with effects that appear to be dose related. Pharmacogenetics demonstrate several associations of Li’s response with circadian genes (NR1D1, GSK3β, CRY1, ARNTL, TIM, PER2). Finally, Li acts on the retinal-hypothalamic pineal pathway, influencing light sensitivity and melatonin secretion. Moreira 2016
At a neuronal level, lithium reduces excitatory (dopamine and glutamate) but increases inhibitory (GABA) neurotransmission Malhi 2013
Pros: Very effective mood stabiliser in most patients - compared to lithium, valproate and olanzapine, least likely to be discontinued or require another medication (Hayes 2016) however it was a cohort study and lithium is first line so likely to be the least ill patients.
Reduces suicide Cipriani 2013
Lithium appears to preserve or increase the volume of brain structures involved in emotional regulation such as the prefrontal cortex, hippocampus and amygdala, possibly reflecting its neuroprotective effects. Reduce
Lithium also appears to protect from apoptosis, promote gray matter growth, especially in the hippocampus, and reduce neural oxidative and nitrosative stress, reduces risk of dementia Malhi 2013, 2016
Cons: Hypothyroidism (which has an effect of depression)
Diabetes insipidus, polydipsia, dehydration, 1/3 CRF after 10-30 years (Aiff 2015)
Teratogen - not significant though. Lamotrigine instead?
Can overdose - nausea, emesis, diarrhoea, ataxia, confusion, lethargy, seizures, coma, renal impairment, death but can usually be reversed fairly well with rehydration and sodium replacement
Neurocognitive effects: verbal memory and verbal learning, processing speed, attention, psychomotor speed, and executive function impaired (Malhi 2016) Bearden found episodic memory, working memory and attention, visual scanning, and processing speed all significantly predicted future occupational status at both baseline and follow-up. BUT very difficult to measure the different domains, could just be illness-progression. (Malhi 2016)

18
Q

What is the aetiology of depression?

A

In fact, it is estimated that only 50% of depressed patients are responsive to currently available antidepressant treatments (Rush et al., 2006)
None of the animal models developed so far perfectly reproduce the depression-like phenotype observed in humans (for review, see Berton and Nestler, 2006). Moreover, unlike other psychiatric disorders, genome-wide association studies have not identified a single risk allele associated with MDD, thus, the field lacks true genetic models of the disease

As adults, the offspring of high licking and grooming mothers are less fearful and characterized by lower hypothalamic–pituitary–adrenal (HPA) responses to stress Tang 2014, Weaver et al. (2004) showed that mother–pup contacts alter the offspring epigenome thus affecting regulation of the glucocorticoid receptor promoter in the hippocampus.
Adult rodents exposed to repeated restraint stress exhibit a depression-like phenotype marked by reduced sucrose preference, anxiety-like exploratory deficits and increased immobility in the forced swim test (FST) (Voorhees 2013) However, following repeated stress, the HPA response is desensitized and no significant increase of corticosterone level is observed after 21 days Magarinos 1995 Pharmacological interventions such as chronic corticosterone administration can also induce long lasting depression-like behaviors in rodents by mimicking the increased stress hormone production observed in a subset of depressed patients (Gourley 2009)
Some genetic models, eg. Wistar Kyoto, social avoidance, anhedonia, relieved by chronic antidepressants, ECT, DBS, Belujon 2014, Flinders Sensitive model Overstreet 2013 (not good in depression without anxiety)
Genetically modified mice expressing a methionine substitution for valine at codon 66 of the BDNF gene (Val66Met) reproduces phenotypic hallmarks of depression as observed in humans (Chen et al., 2006).
In addition, serotonin deficiency induced by tryptophan depletion or tryptophan hydroxylase inhibition can cause depression in both humans (Young, 2013) and rodent models of depression (Berton and Nestler, 2006),
One of the most consistent findings from histopathological studies is lower cortical thickness and cell densities in the prefrontal cortex (PFC) of depressed patients (Rajkowska et al., 1999). Microarray gene profiling has revealed decreased expression of synapse-related genes and loss of excitatory synapses in both the PFC (Kang et al., 2012) and hippocampus (Duric et al., 2013)
changes in depressive behaviors are closely related to persistent remodeling of hippocampal spines and synapses (Hajszan et al., 2009)